C9257 Injection, bevacizumab, 0.25 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Bevacizumab injection

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, bevacizumab, 0.25 mg	yes

C9250 Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
C9254 Injection, lacosamide, 1 mg
C9285 Lidocaine 70 mg/tetracaine 70 mg, per patch
C9293 Injection, glucarpidase, 10 units